期刊
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY
卷 40, 期 3, 页码 366-372出版社
TERMEDIA PUBLISHING HOUSE LTD
DOI: 10.5114/ceji.2015.54601
关键词
oncolytic bacteria; oncolytic viruses; anticancer therapy
类别
资金
- European Regional Development Fund, Operational Program Innovative Economy
- INTER Programme
- European Social Fund
- [K/ZDS/004602]
An idea for a new combination therapy will be described herein. It is a proposition to combine viral and bacterial anticancer therapies and make them fight cancer in concert. We analyzed biological anticancer therapies and found overlapping advantages and disadvantages which led us to the conclusion that the combination therapy has the potential to create a new therapeutic quality. It is surprising how many weaknesses of viral anticancer therapy are the strengths of bacterial anticancer therapies and the other way round. We review the facts behind this concept and try to assess its value. We propose a few strategies how to combine these two therapies but as far as the review can go, final answers will have to come from the experiments. This review is the first attempt to describe a new strategy and understand the means for this idea but also to raise new questions and discuss new ways to look at anti-cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据